We work with leading innovators in pharmaceuticals and medical products to ask the right questions, provide insights, and deliver results. We help clients build capabilities to deliver lasting business impact.

More about this practice 

Our expertise

Proprietary tools & solutions

Our sophisticated tools and solutions help pharmaceutical and medical product companies during the entire product development lifecycle, from discovery through post-launch. Many were created specifically to address the unique challenges that PMP companies confront.more

Latest thinking
Operations for the executive suite
compendium

Operations for the executive suite

Highlights specific opportunities for operations to create significant value upside for pharmacos and emphasizes the role of the executive suite in enabling this value creation

Escaping the sword of Damocles
compendium

Escaping the sword of Damocles: Toward a new future for pharmaceutical R&D

Recent years have seen a collapse in the industry’s R&D productivity. Regaining trust by delivering life-changing new drugs is still an achievable goal, but it will require discipline, creativity, and luck in equal measure. Part of the 2012 R&D compendium.

Death of a sales model, or not
compendium

Death of a sales model, or not

Discusses how pharmaceutical companies will need to adjust their traditional sales models to suit the evolving healthcare landscape (PDF–5.9 MB)more

Outpacing change
compendium

Outpacing change in pharma operations

Reviews our major recommendations for improving pharmaceutical operations and increasing client capabilities.

Meet our people
Michael Silber
Michael Silber
Director
Vivian Hunt
Vivian Hunt
Director
Rajesh Parekh
Rajesh Parekh
Director
More profiles
Featured insights
A wake-up call for Big Pharma
A wake-up call for Big Pharma

McKinsey Quarterly—Lower profit margins suggest a need for new business models.more

Healthcare and social media: A winning combination
Healthcare and social media: A winning formula

This article describes why various healthcare stakeholders are using social media and provides a perspective on how pharmaceutical companies can make the most of it. (PDF–193 KB)more